Cryptosporidium parvum: an emerging occupational zoonosis in Finland.


Journal

Acta veterinaria Scandinavica
ISSN: 1751-0147
Titre abrégé: Acta Vet Scand
Pays: England
ID NLM: 0370400

Informations de publication

Date de publication:
22 Jun 2023
Historique:
received: 14 03 2023
accepted: 24 05 2023
medline: 26 6 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

Cryptosporidiosis has increased in recent years in Finland. We aimed to identify risk factors for human cryptosporidiosis and to determine the significance of Cryptosporidium parvum as a causative agent. Based on notifications to the Finnish Infectious Disease Register (FIDR), we conducted a case-control study and genotyped Cryptosporidium species from patient samples from July to December 2019. We also retrieved the occupational cryptosporidiosis cases from 2011 to 2019 from the Finnish Register of Occupational Diseases (FROD). Of 272 patient samples analyzed, 76% were C. parvum and 3% C. hominis. In the multivariable logistic regression analysis of 82 C. parvum cases and 218 controls, cryptosporidiosis was associated with cattle contact (OR 81, 95% confidence interval (CI) 26-251), having a family member with gastroenteritis (OR 34, 95% CI 6.2-186), and spending time at one's own vacation home (OR 15, 95% CI 4.2-54). Of the cases, 65% had regular cattle contact. The most common gp60 subtypes identified were IIaA15G2R1 and IIaA13G2R1. In FROD, 68 recognized occupational cryptosporidiosis cases were registered in 2011-2019. C. parvum is the most common Cryptosporidium species found in humans in Finland and poses a moderate to high risk of occupational infection for people working with cattle. The number of occupational notifications of cryptosporidiosis increased between 2011 and 2019. Cryptosporidiosis should be recognized as an important occupational disease among persons working with livestock in Finland, criteria to identify occupational cryptosporidiosis need to be created, and occupational safety in cattle-related work should be improved.

Sections du résumé

BACKGROUND BACKGROUND
Cryptosporidiosis has increased in recent years in Finland. We aimed to identify risk factors for human cryptosporidiosis and to determine the significance of Cryptosporidium parvum as a causative agent. Based on notifications to the Finnish Infectious Disease Register (FIDR), we conducted a case-control study and genotyped Cryptosporidium species from patient samples from July to December 2019. We also retrieved the occupational cryptosporidiosis cases from 2011 to 2019 from the Finnish Register of Occupational Diseases (FROD).
RESULTS RESULTS
Of 272 patient samples analyzed, 76% were C. parvum and 3% C. hominis. In the multivariable logistic regression analysis of 82 C. parvum cases and 218 controls, cryptosporidiosis was associated with cattle contact (OR 81, 95% confidence interval (CI) 26-251), having a family member with gastroenteritis (OR 34, 95% CI 6.2-186), and spending time at one's own vacation home (OR 15, 95% CI 4.2-54). Of the cases, 65% had regular cattle contact. The most common gp60 subtypes identified were IIaA15G2R1 and IIaA13G2R1. In FROD, 68 recognized occupational cryptosporidiosis cases were registered in 2011-2019.
CONCLUSIONS CONCLUSIONS
C. parvum is the most common Cryptosporidium species found in humans in Finland and poses a moderate to high risk of occupational infection for people working with cattle. The number of occupational notifications of cryptosporidiosis increased between 2011 and 2019. Cryptosporidiosis should be recognized as an important occupational disease among persons working with livestock in Finland, criteria to identify occupational cryptosporidiosis need to be created, and occupational safety in cattle-related work should be improved.

Identifiants

pubmed: 37349848
doi: 10.1186/s13028-023-00684-z
pii: 10.1186/s13028-023-00684-z
pmc: PMC10286481
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25

Informations de copyright

© 2023. The Author(s).

Références

Appl Environ Microbiol. 2007 Mar;73(6):1892-8
pubmed: 17259359
Int J Parasitol. 2021 Dec;51(13-14):1099-1119
pubmed: 34715087
Prev Vet Med. 2009 Aug 1;90(3-4):242-53
pubmed: 19443061
J Clin Epidemiol. 1990;43(1):87-91
pubmed: 2319285
Pathogens. 2021 Apr 26;10(5):
pubmed: 33926039
Parasitol Int. 2020 Dec;79:102163
pubmed: 32589940
Vet Rec. 2008 Jun 28;162(26):843-5
pubmed: 18587060
Trends Parasitol. 2018 Nov;34(11):997-1011
pubmed: 30108020
J Infect Dis. 2019 Mar 15;219(7):1121-1129
pubmed: 30395258
J Clin Microbiol. 2004 Jul;42(7):2944-51
pubmed: 15243043
Infect Immun. 2000 Jul;68(7):4117-34
pubmed: 10858229
Parasit Vectors. 2021 Jan 22;14(1):69
pubmed: 33482898
J Clin Microbiol. 2005 Jun;43(6):2805-9
pubmed: 15956401
PLoS One. 2012;7(2):e31139
pubmed: 22347442
J Med Microbiol. 2008 Sep;57(Pt 9):1099-1105
pubmed: 18719179
J Clin Microbiol. 2003 Jun;41(6):2744-7
pubmed: 12791920
Exp Parasitol. 2010 Jan;124(1):80-9
pubmed: 19358845
Appl Environ Microbiol. 2020 Sep 17;86(19):
pubmed: 32709724
Parasitol Res. 2006 Sep;99(4):346-52
pubmed: 16565813
Microorganisms. 2021 Nov 20;9(11):
pubmed: 34835519
Trop Parasitol. 2017 Jan-Jun;7(1):8-17
pubmed: 28459010
Vector Borne Zoonotic Dis. 2014 Jan;14(1):1-19
pubmed: 24341911
Parasitology. 2014 Nov;141(13):1667-85
pubmed: 25111501
J Am Coll Health. 2003 Mar;51(5):213-5
pubmed: 12822713
Microorganisms. 2020 Sep 04;8(9):
pubmed: 32899825
Lancet Infect Dis. 2001 Nov;1(4):262-9
pubmed: 11871513
Ann Agric Environ Med. 2011;18(2):286-93
pubmed: 22216801
Epidemiol Infect. 2011 May;139(5):700-12
pubmed: 20619076
Trends Parasitol. 2020 Mar;36(3):290-303
pubmed: 31983609
J Clin Pathol. 2020 Nov;73(11):758-761
pubmed: 32409597
Clin Microbiol Infect. 2016 Jun;22(6):471-80
pubmed: 27172805
Infect Dis (Lond). 2023 Feb;55(2):116-124
pubmed: 36266958
Epidemiol Infect. 2015 Oct;143(13):2748-56
pubmed: 25633822
Vet Parasitol. 2017 Oct 15;245:5-13
pubmed: 28969838

Auteurs

Tuulia Enbom (T)

Animal Health Diagnostic Unit, Finnish Food Authority, Neulaniementie 4, Kuopio, Finland.

Kristiina Suominen (K)

Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, Helsinki, Finland. kristiina.suominen@thl.fi.

Sirpa Laitinen (S)

Occupational Safety, Finnish Institute of Occupational Health, Neulaniementie 4, Kuopio, Finland.

Jukka Ollgren (J)

Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, Helsinki, Finland.

Tiina Autio (T)

Animal Health Diagnostic Unit, Finnish Food Authority, Neulaniementie 4, Kuopio, Finland.

Ruska Rimhanen-Finne (R)

Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH